ESC Professional Premium Access

Anticoagulant therapy beyond primary treatment among active cancer and non-cancer patients with venous thromboembolism in the United States

Congress Presentation

About the speaker

Doctor Alexander Thomas Cohen

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)
15 presentations
0 follower

6 more presentations in this session

Baseline characteristics and outcomes of extended oral anticoagulant treatment in patients with venous thrombosis: a retrospective cohort study in France

Speaker: Mr R. Subash (Surrey, GB)


Comparative effectiveness and safety of apixaban and low-molecular weight heparin among patients with venous thromboembolism and active cancer in an extended treatment setting

Speaker: Doctor A. Cohen (London, GB)


The effect of DOAC-Stop on lupus anticoagulant testing in patients with pulmonary embolism receiving direct oral anticoagulants

Speaker: Professor A. Undas (Krakow, PL)


Clinical characteristics and outcomes of super-low-dose edoxaban of 15 mg in patients with acute venous thromboembolism: insight from the COMMAND VTE Registry-2

Speaker: Doctor K. Kaneda (Kyoto, JP)


Predicting thrombus outcome during anticoagulation for left ventricular thrombus

Speaker: Doctor Q. Yang (Beijing, CN)


Access the full session

Oral anticoagulation in patients with venous thromboembolism or left ventricular thrombus

Speakers: Doctor A. Cohen, Mr R. Subash, Doctor A. Cohen, Professor A. Undas, Doctor K. Kaneda...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by